Evidence Based Evaluation of Traditional Chinese Medicine Prevention and Treatment Program for Children with Influenza

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Patients diagnosed with influenza A (H1N1, H3N2) or influenza B virus according to real-time polymerase chain reaction (PCR) or virus culture;
•(2) Aged 5 to 14 years;
•(3) Armpit temperature >= 38 degrees C;
•(4) At least 2 systemic symptoms (headache, chills, myalgia or fatigue) and 1 respiratory symptom (cough, sore throat or rhinitis);
•(5) Those who meet the diagnostic criteria of TCM syndromes;
•(6) The course of the disease is within 72 hours;
•(7) Sign a written informed consent.

•(1) Bronchitis, pneumonia, pleural effusion and interstitial lung disease confirmed by chest imaging (x-ray examination or CT);
•(2) Blood routine examination indicated bacterial infection;
•(3) purulent tonsillitis or purulent sputum;
•(4) Having primary diseases, such as blood diseases, bronchial asthma, liver diseases, kidney diseases, chronic congestive heart failure, and neurological diseases;
•(5) Antiviral drugs (amantadine, rimantadine, zanamivir or oseltamivir phosphate) were taken before the onset and inclusion of the study, or Chinese herbal medicines or proprietary Chinese medicines were taken.
•(6) Allergic to research drugs;
•(7) Take immunosuppressants within the last 3 months;
•(8) Participate in another clinical trial < 3 months prior to study randomization;
•(9) Acute respiratory infection, otitis or sinusitis 2 weeks before study inclusion;
•(10) Influenza vaccination within 6 months;
•(11) Other reasons suggested by the researchers. See Table 4 for inclusion and exclusion criteria.

发起方

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine